Division of Preventive Medicine, Clinical Research Institute for Endocrine and Metabolic Disease, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
J Clin Biochem Nutr. 2009 Nov;45(3):329-34. doi: 10.3164/jcbn.09-26. Epub 2009 Oct 28.
Low caloric diet (LCD) is used for weight loss. Paraoxonase 1 (PON-1) is associated with the antioxidant functions of high-density lipoprotein (HDL). Among limited data on the relationships between obesity and PON-1, there has been no study on the effects of a stand-alone LCD on the physiological lactonase activity of PON-1. We investigated the prospective effects of LCD intervention (2 months) for weight loss on serum PON-1 activities (lactonase, arylesterase [mono-esterase] and tri-esterase) and HDL cholesterol (HDL-C), and their association with low-density lipoprotein cholesterol (LDL-C) in overweight and non-morbidly obese but otherwise healthy women (n = 30; mean age, 50.3 years; mean body mass index [BMI], 28.5 kg/m(2)). In addition to the data such as BMI, blood pressure, blood glucose and lipids, PON-1 activities were examined between pre- and post-intervention. The intervention reduced all metabolic outcomes, and PON-1 lactonase activity (determined with 5-[thiobutyl]butyrolactone) significantly decreased by 6.1%, paralleled by arylesterase (by 7.3%) and tri-esterase (by 7.8%). In multiple regression analysis, the percent change of PON-1 lactonase was significantly, positively and independently correlated to that of LDL-C (beta = 0.51), HDL-C (beta = 0.40), and BMI (beta = 0.37). Our results showed that the solo diet treatment on weight loss might reduce serum PON-1 lactonase activity with reduced HDL-C and LDL-C. The relationship between the lactonase and LDL-C may be adaptive, plausibly hypothesizing less need for PON-1 activity as an antioxidant property to protect lipoproteins. Further research is needed to confirm this prediction.
低热量饮食(LCD)用于减肥。对氧磷酶 1(PON-1)与高密度脂蛋白(HDL)的抗氧化功能有关。在肥胖与 PON-1 之间关系的有限数据中,尚未有研究探讨单独的 LCD 对 PON-1 生理内酯酶活性的影响。我们研究了 LCD 干预(2 个月)减肥对超重且非病态肥胖但其他健康女性(n = 30;平均年龄 50.3 岁;平均 BMI[体重指数]28.5 kg/m²)血清 PON-1 活性(内酯酶、芳基酯酶[单酯酶]和三酯酶)和 HDL 胆固醇(HDL-C)的影响,及其与 LDL-C 的关系。除了 BMI、血压、血糖和血脂等数据外,还在干预前后检查了 PON-1 活性。干预降低了所有代谢结果,PON-1 内酯酶活性(用 5-[硫丁基]丁内酯测定)显著降低了 6.1%,芳基酯酶降低了 7.3%,三酯酶降低了 7.8%。在多元回归分析中,PON-1 内酯酶的百分比变化与 LDL-C(β=0.51)、HDL-C(β=0.40)和 BMI(β=0.37)呈显著正相关且独立相关。我们的结果表明,单独的饮食治疗对体重减轻可能会降低血清 PON-1 内酯酶活性,同时降低 HDL-C 和 LDL-C。内酯酶与 LDL-C 之间的关系可能是适应性的,推测是因为脂蛋白的抗氧化特性对 PON-1 活性的需求减少。需要进一步研究来证实这一预测。